The Hemophilia B Market Is Expanding Due To Rising Awareness And Improved Diagnosis Of Rare Bleeding Disorders
Hemophilia B Market Overview The hemophilia B market is a specialized segment of the global rare disease and hematology therapeutics industry. Hemophilia B is a rare inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX, leading to prolonged bleeding episodes, spontaneous hemorrhages, and joint damage. The condition primarily affects males and...
0 Kommentare 0 Geteilt 15 Ansichten 0 Bewertungen